Oren Ilan bought ROIV
October 20, 2025 · Form 4 insider transaction
Oren Ilan bought 1,507 shares of Roivant Sciences Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,507
Price
$0.00
Total value
N/A
InsiderOren Ilan
RoleDirector
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateOctober 20, 2025
Filing dateOctober 22, 2025
Shares owned after118,669
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.